All company structures are involved at different levels in the drug manufacturing process...
The portfolio of A. Menarini GmbH consists of medicinal products for primary patient care, i.e. products that are predominantly prescribed by general practitioners and the appropriate specialists.
Discover more about Menarini Group
History
A. Menarini GmbH, the Swiss subsidiary of the Menarini Group, was established in Zurich in 1996. The first products marketed in Switzerland were in the indication fields of pain and inflammation.
These were soon followed by further products in other areas of application, including high blood pressure and shingles, averaging almost one product launch a year!
The number of employees thus increased constantly, and today A. Menarini GmbH employs more than 40 people in the fields of authorisation, medicine, marketing, sales and finance. More than half the workforce is employed in our field service, which supports our endeavour to enter into effective, qualified and reliable cooperation with all our customers.
A history of quality: the milestones
The “Farmacia Internazionale Menarini” opens in Naples
Menarini opens its Florence premises.
Alberto Aleotti is appointed Director General of “Farmaceutica Menarini” and Internationalisation is launched with “Laboratorios Menarini” in Barcelona.
Opening of Menarini Research&Development Division.
Menarini has expanded its international business rapidly.
Acquisition of Berlin-Chemie which opens up Central-East Europe markets to Menarini.
Opening of the Swiss subsidiary A. Menarini GmbH in Zurich
Opening of Menarini Biotech in Pomezia (Rome).
Lucia e Alberto Giovanni Aleotti leading Menarini.
Acquisition of the Invida Group consolidating Menarini's presence in the Asia Pacific markets.
Acquisition of Silicon Biosystems.
VaxYnethic, a joint venture between Menarini and NewTech Biosynth in vaccines.
CellSearch, pioneer in advanced technologies for cancer diagnostics
Dr Eric Cornut was appointed as new Chairman of the Menarini Group